Fetuin-A downregulates the glucose uptake of skeletal muscle by suppressing phosphorylation of Akt, AS160, and intracellular GLUT4 translocation to the plasma membrane, resulting in obesity, IR, and NAFLD (Ou et al., 2012). This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.